proimmune产品中国地区授权代理商优势促销，低折扣 短货期

来自 : 发布时间：2024-05-07

Catalog Pro5® MHC Class I PentamersPentamers by Research AreaAdenovirusHCVMalariaSIVAutoimmunityHIVmiHAgTrypanosomaCancerHPVModel AntigenTuberculosisChlamydiaHTLVNegativeVacciniaCMVInfluenzaOtherVSVEBVLCMVRSVWest Nile VirusHBVListeriaSendai VirusYellow Fever 
Adenovirus
Publications citing Adenovirus Pentamers
ALLELEPEPTIDE CODEPEPTIDE SEQUENCEStock/
AvailableEPITOPE ORIGINA*01:01686TDLGQNLLYAAdenovirus 5 Hexon 886-894A*24:02684TYFSLNNKFAAdenovirus 5 Hexon 37-45B*07:02989KPYSGTAYNALA

Adenovirus Hexon 114-124

 Autoimmunity
Publications citing AutoImmunity Pentamers
Case studies of Customer Research into AutoImmunity
ALLELEPEPTIDE CODEPEPTIDE SEQUENCEStock/
AvailableEPITOPE ORIGINA*02:01151KLQVFLIVLAT1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13A*02:01954LNIDLLWSVAT1D Diabetes IGRP 228–236A*02:01851HLVEALYLVAInsulin B chain 10-18A*02:01393VMNILLQYVAGAD65 114-123A*02:01470SLSRFSWGAAMyelin basic protein 110-118A*02:011904VLFGLGFAIA

T1D Diabetes IGRP 265-273

 (back to top)
 
Cancer
Publications Citing Cancer Pentamers
Case Studies of Customer Research into Cancer
ALLELEPEPTIDE CODEPEPTIDE SEQUENCEStock/
AvailableEPITOPE ORIGINA*01:01307KSDICTDEYATyrosinase 243-251 (244S)A*02:012291AILALLPALAProstate Stem Cell Antigen (PSCA) 105-133A*02:011920ALLTSRLRFIATelomerase Reverse Transcriptase (hTRT) 615-624A*02:012083FLAEDALNTVAEpithelial Discoidin Domain Receptor 1 (EDDR1) 867-876A*02:012079FLYDDNQRVATopoisomerase II-alpha-b 828-836A*02:011386GLAPPQHLIRVAp53 187-197A*02:01468ILSLELMKLAReceptor for hyaluronic acid–mediated
motility (RHAMM) 165-173A*02:011464LTLGEFLKLASurvivin-3A 96-104A*02:012299SLPPPGTRVAp53 149-157 A*02:011403VIMPCSWWVAChondromodulin-I 319-327A*02:011201YMCSFLFNLAEwingTumor EZH2 666-674A*02:01061YMDGTMSQVATyrosinase 369-377 (371D)A*02:01447YLQVNSLQTVATelomerase Reverse Transcriptase (hTRT) 988-997A*02:01 859KLQDASAEVAHM1.24-aa 126-134A*02:01329ILLWQPIPVAProstatic Acid Phosphatase-3 (PAP-3) 135-143A*02:01560GLMEEMSALAHuman Mena protein (overexpressed in breast cancer)A*02:01813FVGEFFTDVAGPC3 144-152 (overexpressed in hepatocellular carcinoma)A*02:01075YLSGANLNLSCarcinogenic Embryonic Antigen (CEA) 571-579A*02:01157VLYRYGSFSVAgp100 (pmel17) 476-485A*02:01250VLQELNVTVSLeukocyte Proteinase-3 (Wegeners autoantigen) 169-177A*02:01097VISNDVCAQVAProstate Specific Antigen-1 (PSA-1) 154-163A*02:01390SLLMWITQVANY-ESO-1 157-165A*02:01212RLLQETELVSHER-2/neu 689-697A*02:01810LIAHNQVRQVAHER-2/neu 85–94A*02:01690LLHETDSAVAPSMA/PSM-P1 4-12A*02:01599ALDVYNGLLAProstatic acid phosphatase precursor (PAP) 299-307A*02:01645YLNTVQPTCVAEGF-R 1138-1147A*02:01781VLDGLDVLLAPRAME 100-108A*02:01689VLAGGFFLLAPSMA 27-38A*02:01394YLFFYRKSVAmTERT 572-580A*02:01034FLWGPRALVAMAGEA3 271-279A*02:01646KLFGTSGQKTAEGF-R-479 350-359A*02:01915TLPGYPPHVAPAX-5 311-319A*02:011056SLFLGILSVACD20 188-196 (B cell malignancies)A*02:01117RLVDDFLLV ATelomerase Reverse Transcriptase 865-873A*02:01208LLLLTVLTVAMUC-1 12-20A*02:01205LLGRNSFEVAp53 264-272A*02:01600ALFDIESKVAPSM P2 (prostate)A*02:011013FLGYLILGVAProstatic Acid Phosphatase-3 (PAP-3)A*02:01561TMNGSKSPVAhMena 502-510A*02:01391LMLGEFLKLSSurvivin 96-104A*02:01338QLCPICRAPVALivin/ML-IAP280 175-184A*02:011181SLSEKTVLLACD59 glycoprotein precursor 106-114A*02:01958SLVDVMPWLACytochrome p450 1B1 239-248A*02:01214KIFGSLAFLAHER-2/neu 369-377A*02:01046IMDQVPFSVSgp100 (pmel17) 209-217A*02:01210ILHNGAYSLAHER-2/neu 435-443A*02:01085ILAKFLHWLSTelomerase 540-548A*02:01249HLSTAFARVAG250 (renal cell carcinoma) 217-225A*02:01125GVLVGVALI ACarcinogenic Embryonic Antigen (CEA) 694-702A*02:01527ALYVDSLFFLAPRAME PRA 300–309A*02:01405KLQCVDLHVAProstate Specific Antigen 146-154A*02:01086ALQPGTALLAProstate Stem Cell Antigen (PSCA) 14-22A*02:01302KVAELVHFLAMAGEA3 112-120A*02:01057KTWGQYWQVAgp100 (pmel17) 154-162A*02:01389GLYDGMEHLAMAGEA-10 254-262A*02:01404FLTPKKLQCVAProstate Specific Antigen-1 (PSA-1) 141-150A*02:01082ELAGIGILTVsMelanA / MART 26-35A*02:01171KVLEYVIKVAMAGEA1 278-286A*02:012293GLQHWVPELABA46 (Lactadherin) 97-106A*02:012294GVRGRVEEIAbcr-abl fusion proteinA*02:01048YLSGADLNLACarcinoembryonic antigen (CEA)-derived peptide CAP1-6DA*02:012296ITDQVPFSVAgp100 (pmel) 209-217A*02:01047YLEPGPVTVAgp100 (pmel) 280-288 (288V)A*02:012301YLQLVFGIEVAMAGEA2 157-166A*02:012298KVAEELVHFLAMAGEA3 112-120 (alternative version)A*02:01049SLLMWITQCANY-ESO-1 157-165 (9C)A*02:012300YLGSYGFRLAp53 103-111 A*02:012297KLCPVQLWVAp53 139-147 A*02:01654RMPEAAPPVAp53 65-73A*02:011787RLTSRVKALATelomerare Reverse Transcriptase (hTRT) 653-661A*02:011786GLLGASVLGLATelomerase Reverse Transcriptase (hTRT) 674-683A*02:01381LLLTVLTVVATumor Mucin Antigen 13-21A*03:01118ALLAVGATKAgp100 (pmel17) 17-25A*03:01264ATGFKQSSKAbcr-abl 210 kD fusion protein 259-269A*03:01087KQSSKALQRSbcr-abl 210 kD fusion protein 21-29A*03:01541RISTFKNWPKASurvivin-3A 18-27 (27K)A*24:02416EYLQLVFGIAMAGEA2 156-164A*24:02421TFPDLESEFAMAGEA3 97-105A*24:02209TYACFVSNLACarcinogenic Embryonic Antigen (CEA) 652-660A*24:02417TYLPTNASLAHER-2/neu 63-71A*24:02418VYGFVRACLATelomerase reverse transcriptase (hTRT) 461-469A*24:02230AFLPWHRLFATyrosinase 188-196A*24:022303CYASGWGSIAProstate Specific Antigen-1 153-161A*24:02238VYFFLPDHLAgp100-intron 4 170-178A*24:021806RYCNLEGPPIALymphocyte antigen 6 complex locus K (LY6K) 177-186A*24:022302AYACNTSTLASurvivin 80-88B*07:022304LPWHRLFLLATyrosinase 208-216B*08:01094GFKQSSKALAbcr-abl 210 kD fusion protein 19-27B*35:012307MPFATPMEAANY-ESO-1 94-102H-2 Db1731ATFKNWPFLAMurine Survivin 20-28H-2Db695Abu-Abu-L-Abu-LTVFLAMoloney murine sarcoma virus (MoMSV) GagL 85–93 H-2Db2199FSNSTNDILIAVEGFR2/KDR fragment 1 614-624H-2Db1333KVPRNQDWLAgp100 (pmel17) 25-33H-2Kb185SVYDFFVWLATyrosinase related protein-2 180-188H-2Kb351HNTQYCNLAMAGEA5 5-12H-2Kb2311TVSEFLKLAMurine Survivin 97-104H-2Kd0275DYWGQGTELASurface IgG (sA20-Ig) of A20 106-114H-2Kd814EYILSLEELAGPC3 298-306H-2Kd343TYVPANASLAneu/HER-2/Erbb2 proto-oncoprotein 66-74H-2Ld150LPYLGWLVFA

Tumour Antigen P815 35-43

 (back to top)